Plantar Fasciitis Treatment Market Size, Share, And Growth Report 2032

Plantar Fasciitis Treatment Market: Size

The global Plantar Fasciitis Treatment Market size was worth around USD 1371.07 million in 2023 and is predicted to grow to around USD 3077.62 million by 2032 with a compound annual growth rate (CAGR) of roughly 9.4% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Plantar Fasciitis Treatment Market on a global and regional level.

Request Free Sample

Plantar Fasciitis Treatment Market: Overview

Plantar fasciitis is among the most common cause of injury related to the feet. It affects the heel portion of the foot and results into tenderness of the sole. It is a type of muscle sole inflammation and is highly prevalent among the people who stand on hard surfaces for long periods of time. This disease has emerged as a persistent repetitive strain injury which also afflicts hikers, runners, and walkers, and also those who stands for their living.

In-depth secondary research is used to ascertain overall market size, top industry players, top product, industry associations, etc. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, GDP along with company websites, company annual reports, white papers, financial reports and other saws have also been considered to arrive at the indicated market numbers.

The study also includes drivers and restraints for the plantar fasciitis treatment along with the impact they have on the demand over the forecast period. Besides, the report includes the study of opportunities and trends available in the plantar fasciitis treatment market on global level. There has been wide range of treatments which are a promising ally combating severe pain caused due to plantar fasciitis, thus widening the scope of market growth for stakeholders. Large portion of the working class stands for sustained and longer time during their job and suffer from body pain, specifically foot and ankle pain which is among the predominant cause of plantar fasciitis and has also attributed to the fact that, that manufacturing sector continues to expand at an unprecedented rate of the global population engaged in this industry, who stands at one position for a long duration.

Plantar Fasciitis Treatment Market: Segmentation

The study provides a decisive view on the plantar fasciitis treatment market by segmenting the market based on type, end user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

The plantar fasciitis treatment market is segmented on the basis of type into medication therapy, orthotics, shockwave therapy, surgery, and others. The medication therapy market is further segmented into oral, and parenteral. The shockwave therapy market is further segmented into extracorporeal shock wave therapy, and intracorporeal pneumatic shockwave therapy. Shockwave therapy segment is likely to grow at high CAGR in the forecast period. Plantar fasciitis is gaining momentum due to common foot pain conditions which has also raised the number of treatments globally.

By end user the market is segmented into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment held major share of the market in terms of revenue in 2023 since medication therapy has gained traction due to most widely adopted line of therapy to manage symptoms related to plantar fasciitis like inflammation and pain.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries. Asia Pacific is likely to grow at high CAGR in the forecast period.

Plantar Fasciitis Treatment Market: Report Scope

Plantar Fasciitis Treatment Market: Competitive Players

The report also provides company market share analysis in order to give a broader view of the key players in the market. Industry insights and information is delivered in the required format. ZMR develops a list of industry players (manufacturers), distributors, retailers and industry experts. Some of the players in the market for plantar fasciitis treatment include:

• A. Algeo Limited
• Superfeet Worldwide Inc.
• Hanger Inc.
• Bayer Group (Dr. Scholl's)
• GlaxoSmithKline Plc
• Bauerfeind AG
• Pfizer Inc.
• Sanofi
• Ottobock SE & Co.
• KGaA. (Ottobock Holding)

The Global Plantar Fasciitis Treatment Market is segmented as follows:

Global Plantar Fasciitis Treatment Market: Type Segment Analysis

• Medication Therapy
  • Oral
  • Parenteral
• Orthotics
• Shockwave Therapy
  • Extracorporeal Shock Wave Therapy (ESWT)
  • Intracorporeal Pneumatic Shockwave Therapy (IPST)
• Surgery
• Others

Global Plantar Fasciitis Treatment Market: End User Segment Analysis

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Global Plantar Fasciitis Treatment Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa